Literature DB >> 9568543

Role of nitric oxide in the regulation of lymphocyte apoptosis and HIV-1 replication.

E Hermann1, T Idziorek, J P Kusnierz, Y Mouton, A Capron, G M Bahr.   

Abstract

Nitric oxide (NO) has been implicated in certain immunopathogenetic mechanisms during the course of infection with human immunodeficiency virus (HIV). We have evaluated the levels of NO release and lymphocyte apoptosis in peripheral blood mononuclear cell (PBMC) cultures from HIV-1 infected subjects and healthy controls. We have also examined these 2 parameters in parallel cultures maintained under conditions where either NO synthesis was inhibited or high level of NO was present. Nitrite contents in culture supernatants were measured as the stable end products of the released NO. Levels of spontaneous apoptosis and activation-induced cell death (AICD) by anti-CD3 or by phytohemagglutinin were evaluated using flow cytometry. Additional experiments were also aimed at addressing a potential link between NO synthesis and HIV-1 replication in human monocyte-derived macrophages (MDMs). Acutely infected MDMs with HIV-1Bal were maintained in culture, without any additional activation signal, for a period of 14 days. Nitrites in the supernatants and mRNA accumulation of the inducible NO synthase (iNOS) in infected cells were assessed over the whole culture period. In addition, the effect of blocking NO synthesis during and after infection of MDMs, using an inhibitor of NO, was evaluated on the level of viral replication as measured by the presence of P24 antigen in the supernatants. Similarly, the effect on HIV replication of high NO levels in MDM cultures, supplied by a donor of NO during the 24 h period of infection, was also studied. We conclude that no elevation in NO release could be detected in PBMC cultures from HIV-1 infected subjects and that modulation of NO content may slightly regulate the level of spontaneous lymphocyte apoptosis but not that of AICD. Infection of MDMs with HIV-1 does not seem to induce detectable NO release or iNOS mRNA accumulation. Similarly, neither inhibition of NO synthesis nor the presence of high NO levels during the infection period could modify the outcome of virus replication in macrophages.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9568543     DOI: 10.1016/s0192-0561(97)00060-x

Source DB:  PubMed          Journal:  Int J Immunopharmacol        ISSN: 0192-0561


  7 in total

1.  Critical role of nitric oxide during the apoptosis of peripheral blood leukocytes from patients with AIDS.

Authors:  M D Mossalayi; P A Becherel; P Debré
Journal:  Mol Med       Date:  1999-12       Impact factor: 6.354

2.  Regulation of human immunodeficiency virus type 1 replication in human T lymphocytes by nitric oxide.

Authors:  J L Jiménez; J González-Nicolás; S Alvarez; M Fresno; M A Muñoz-Fernández
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

3.  Recombinant interleukin-16 selectively modulates surface receptor expression and cytokine release in macrophages and dendritic cells.

Authors:  E Hermann; E Darcissac; T Idziorek; A Capron; G M Bahr
Journal:  Immunology       Date:  1999-06       Impact factor: 7.397

4.  CCTTT-repeat polymorphism of the inducible nitric oxide synthase is not associated with HIV pathogenesis.

Authors:  M Hersberger; S Bonhoeffer; S K Rampini; M Opravil; J Marti-Jaun; A Telenti; E Hänseler; B Ledergerber; R F Speck
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

5.  Role of indoleamine-2,3-dioxygenase in alpha/beta and gamma interferon-mediated antiviral effects against herpes simplex virus infections.

Authors:  O Adams; K Besken; C Oberdörfer; C R MacKenzie; O Takikawa; W Däubener
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

Review 6.  Critical role of nitric oxide in impeding COVID-19 transmission and prevention: a promising possibility.

Authors:  Rajalakshmi Rajendran; Anjana Chathambath; Abdullah G Al-Sehemi; Mehboobali Pannipara; Mazhuvancherry Kesavan Unnikrishnan; Lotfi Aleya; Roshni Pushpa Raghavan; Bijo Mathew
Journal:  Environ Sci Pollut Res Int       Date:  2022-03-08       Impact factor: 5.190

7.  Antitubercular therapy decreases nitric oxide production in HIV/TB coinfected patients.

Authors:  Ajay Wanchu; Archana Bhatnagar; Madhu Khullar; Archana Sud; Pradeep Bambery; Surjit Singh
Journal:  BMC Infect Dis       Date:  2002-07-29       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.